%) and IPD (10%). This promising growth was due to more subspecialties, more Operation : Consolidated Profit & Loss Statement 2Q 2Q % 6 mth 6 mth % Unit : THB million 2019 2018 change 2019 2018 change

) Locating the right target audience and drive product awareness with 100% view-ability, 2) Encouraging products to sampled at home, where consumers are generally more receptive, 3) Obtaining product user

investment grew 4.2% in Q4 versus the same period in 2017 and up 3.9% from Q3. Private-sector investment expenditure on machinery and equipment picked up pace and this industrial expansion is encouraging. The

from July 2020 with a promising growth. 2 Profit/(Loss) After Taxation (“PAT”)/(“LAT”) 2.1 PAT/(LAT) for the 3-months ended 31 July 2020 INGRS registered loss after taxation of Baht 107.53 million for

) For the next financial year ending 31 January 2022 (“FY2021/22”), INGRS is looking for a promising improvement in automotive industry. In general, from the forecast released by automotive association

% decrease. The promising growth of non-SW revenue was from IPD (49% growth) followed by OPD (14% growth) yoy. Both number of patients and revenue per head of 4Q19 increased. The higher revenue per head

%). This promising growth was due to more subspecialties as well as capacity expansion. OPD increased by 3 units and IPD increased by 17 units yoy. Number of OPD patients remained on the rise while revenue

net profit after deduction of NCI nevertheless increased by 11% yoy. This promising performance was mainly due to the increase of income coupled with wider gross margin as mentioned above. Page 3 of 4

the food and beverage business under brand Dean & DeLuca whereby the Company is promising to continue developing the projects. Please be informed accordingly. Yours sincerely, - Signed – (Mr. Sorapoj

% yoy. EBITDA margin rose from 26% of hospital revenue in 3Q18 to 28% in 3Q19. The promising EBITDA was attributable to not only the revenue growth but also the effective cost control as mentioned above